Advertisement
Home »

Adeno-associated virus vector hydrogel formulations for brain cancer gene therapy applications.

Jan 15, 2024

ABOUT THE EXPERTS

  • Żaneta Słyk

    Department of Applied Pharmacy, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland; Laboratory of Gene Therapy, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland. Electronic address: zaneta.slyk@wum.edu.pl.

    Robert Wrzesień

    Central Laboratory of Experimental Animals, Center for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.

    Sławomir Barszcz

    Department of Neurosurgery, Children’s Clinical Hospital, University Clinical Centre of the Medical University of Warsaw, Warsaw, Poland.

    Krzysztof Gawrychowski

    Department of Applied Pharmacy, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.

    Maciej Małecki

    Department of Applied Pharmacy, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland; Laboratory of Gene Therapy, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement